home>bioprinting>Publications.html Seite teilen:

Publications:

Articles (peer reviewed):

Nothdurfter D, Ploner C, Coraça-Huber DC, Wilflingseder D, Müller T, Hermann M, Hagenbuchner J*, Ausserlechner MJ*. (2022) 3D bioprinted, vascularized neuroblastoma tumor environment in fluidic chip devices for precision medicine drug testing. Biofabrication, 14(3). doi: 10.1088/1758-5090/ac5fb7

Kuznetsov AV*, Javadov S, Margreiter R, Hagenbuchner J, Ausserlechner MJ* (2022) Analysis of Mitochondrial Function, Structure, and Intracellular Organization In Situ in Cardiomyocytes and Skeletal Muscles. International Journal of Molecular Sciences, 23, 2252. doi.org/10.3390/ijms23042252

Fiegl H, Hagenbuchner J, Kyvelidou C, Seeber B, Sopper S, Tsibulak I, Wieser V, Reiser E, Roessler J, Huhtinen K, Carpén O, Parson W, Sprung S, Marth C, Ausserlechner MJ*, Zeimet AG* (2022). Dubious effects of methadone as an "anticancer" drug on ovarian cancer cell-lines and patient-derived tumor-spheroids. Gynecologic Oncology Jan 12:S0090-8258(22)00009-9. doi: 10.1016/j.ygyno.2022.01.008. Epub ahead of print. PMID: 35033381.

Alatibi KI, Tholen S, Wehbe Z, Hagenbuchner J, Daniela Karall D, Ausserlechner MJ, Schilling O, Grünert SC, Vockley J, Tucci S (2021) Lipidomic and Proteomic Alterations Induced by Even and Odd Medium-Chain Fatty Acids on Fibroblasts of Long-Chain Fatty Acid Oxidation Disorders. International Journal of Molecular Sciences, 22, 10556. doi:10.3390/ijms221910556

Hagenbuchner J, Nothdurfter D, Ausserlechner MJ* (2021) 3D-bioprinting: Novel approaches for engineering complex human tissue equivalents and drug testing. Essays in Biochemistry, 65(3):417-427. doi: 10.1042/EBC20200153.

Alatibi KI, Hagenbuchner J, Wehbe Z, Karall D, Ausserlechner MJ, Vockley J, Spiekerkoetter U, Grünert SC, Tucci S. (2021) Different Lipid Signature in Fibroblasts of Long-Chain Fatty Acid Oxidation Disorders. Cells. 18;10(5):1239. doi: 10.3390/cells10051239.

Kuznetsov AV, Javadov S, Margreiter R, Grimm M, Hagenbuchner J, Ausserlechner MJ*. (2021) Structural and functional remodeling of mitochondria as an adaptive response to energy deprivation. Biochim Biophys Acta Bioenerg. 1862(6):148393. doi: 10.1016/j.bbabio.2021.148393. Epub 2021 Feb 5.

Kuznetsov AV, Javadov S, Grimm M, Margreiter R, Ausserlechner MJ, Hagenbuchner J. (2020) Crosstalk between Mitochondria and Cytoskeleton in Cardiac Cells. Cells. Jan 16;9(1). pii: E222. doi: 10.3390/cells9010222.

Salcher S, Spoden G, Huber JM, Golderer G, Lindner H, Ausserlechner MJ, Kiechl-Kohlendorfer U, Geiger K, Obexer P. (2019). Repaglinide Silences the FOXO3/Lumican Axis and Represses the Associated Metastatic Potential of Neuronal Cancer Cells. Cells. 2019 Dec 18;9(1). pii: E1. doi: 10.3390/cells9010001. PubMed

Hagenbuchner J, Obsilova V, Kaserer T, Kaiser N, Rass B, Psenakova K, Docekal V, Alblova M, Kohoutova K, Schuster D, Aneichyk T, Vesely J, Obexer P, Obsil T, Ausserlechner MJ. (2019). Modulating FOXO3 transcriptional activity by small, DBD-binding molecules. Elife. 2019 Dec 4;8. pii: e48876. doi: 10.7554/eLife.48876. PubMed

Salcher S, Spoden G, Hagenbuchner J, Führer S, Kaserer T, Tollinger M, Huber-Cantonati P, Gruber T, Schuster D, Gust R, Zwierzina H, Müller T, Kiechl-Kohlendorfer U, Ausserlechner MJ, Obexer P. (2019). A drug library screen identifies Carbenoxolone as novel FOXO inhibitor that overcomes FOXO3-mediated chemoprotection in high-stage neuroblastoma. Oncogene. 2019 Oct 7. doi: 10.1038/s41388-019-1044-7. PubMed

Kuznetsov AV, Javadov S, Margreiter R, Grimm M, Hagenbuchner J, Ausserlechner MJ (2019). The Role of Mitochondria in the Mechanisms of Cardiac Ischemia-Reperfusion Injury. Antioxidants (Basel). 8(10). pii: E454. doi: 10.3390/antiox8100454. PubMed

Psenakova K., Kohoutova K., Obsilova V., Ausserlechner M.J., Veverka V., Obsil T (2019). Forkhead Domains of FOXO Transcription Factors Differ in both Overall Conformation and Dynamics. Cells 8(9). pii: E966. doi: 10.3390/cells8090966. PubMed

Hagenbuchner J., Oberacher H., Arnhard K., Kiechl-Kohlendorfer U., Ausserlechner M.J. (2019) Modulation of respiration and mitochondrial dynamics by Smac-mimetics for combination therapy in chemoresistant cancer. Theranostics 9(17):4909-4922. doi: 10.7150/thno.33758. eCollection 2019. PubMed

Hagenbuchner J., Scholl-Buergi, S., Karall, D., Ausserlechner, M.J. (2018) Very long-/ and long Chain-3-Hydroxy Acyl CoA Dehydrogenase Deficiency correlates with deregulation of the mitochondrial fusion/fission machinery. Scientific Reports 19;8(1):3254. doi: 10.1038/s41598-018-21519-2. PubMed

Rupp M., Hagenbuchner J., Rass B., Fiegl H., Kiechl-Kohlendorfer U., Obexer P., Ausserlechner M.J. (2017) FOXO3-mediated chemo-protection in high-stage neuroblastoma depends on wild-type TP53 and SESN3. Oncogene. 36(44): 6190-6203. doi: 10.1038/onc.2017.288. PubMed

Salcher S., Hermann M., Kiechl-Kohlendorfer U., Ausserlechner M.J., Obexer P. (2017) C10ORF10/DEPP-mediated ROS accumulation is a critical modulator of FOXO3-induced autophagy. Mol Cancer. 16(1):95. doi: 10.1186/s12943-017-0661-4. PubMed

Hagenbuchner, J., Lungkofler, L., Kiechl-Kohlendorfer, U., Viola, G., Ferlin, M.G., Ausserlechner, M.J., Obexer, P. (2017) The tubulin-inhibitor MG-2477 induces autophagy-regulated cell death and activation of FOXO3 in neuroblastoma. Oncotarget, 8(19):32009-32026. PubMed

Hagenbuchner, J., Rupp, M., Salvador, C., Meister, B.,  Kiechl-Kohlendorfer, U., Thomas Müller, T., Geiger, K., Sergi, C., Obexer, P., Ausserlechner, M.J. (2016) Nuclear FOXO3 predicts adverse clinical outcome and promotes tumorangiogenesis in neuroblastoma in vivo. Oncotarget, 7(47):77591-77606. doi: 10.18632/oncotarget.12728. PubMed

Hagenbuchner J., Kiechl-Kohlendorfer U., Obexer P., Ausserlechner M.J. (2016) BIRC5/Survivin as target for glycolysis inhibition in high-stage neuroblastoma. Oncogene, 35(16):2052-61. doi: 10.1038/onc.2015.264. PubMed

Schäfer S, Salcher S, Seiter M, Ranninger C, Möst M, Obexer P, Huber CG, Ausserlechner M.J., Schwaiger S, Stuppner H (2016). Characterization of the XIAP-Inhibiting Proanthocyanidin Fraction of the Aerial Parts of Ephedra sinica. Planta Med. 82(11-12):973-85. doi: 10.1055/s-0042-107253. PubMed

Hagenbuchner J., and Ausserlechner M.J. (2016). Transcription factors as drug targets for small chemical compounds. Biochemical Pharmacology, 107:1-13. doi: 10.1016/j.bcp.2015.12.006 PubMed

Ausserlechner M.J., Hagenbuchner J. Mitochondrial survivin – an Achilles’ heel in cancer chemoresistance (2015). Molecular and Cellular Oncology, (invited Author’s view), 29;3(2):e1076589. doi: 10.1080/23723556.2015.1076589. PubMed

Salcher S, Hagenbuchner J, Geiger K, Seiter M.A, Rainer J, Kofler R, Hermann M, Kiechl-Kohlendorfer U, Ausserlechner M.J. Obexer P., (2014). C10ORF10/DEPP, a transcriptional target of FOXO3, regulates ROS-sensitivity in human neuroblastoma, Mol Cancer. 13(1):224. PubMed

Seiter M., Salcher S., Rupp M., Hagenbuchner J., Kiechl-Kohlendorfer U., Mortiere J., Wolber G., Rollinger JM., Obexer P., Ausserlechner M.J.  (2014) Discovery of Sanggenon G as a natural cell-permeable small-molecular weight inhibitor of X-linked inhibitor of apoptosis protein (XIAP), FEBS open bio, 4, 659. PubMed

Obexer, P., Ausserlechner, M.J. (2014) X-linked inhibitor of apoptosis (XIAP) – a critical death-resistance regulator and therapeutic target for personalized cancer therapy. Frontiers in Oncology, Jul 28;4:197. PubMed

Hagenbuchner,J. and Ausserlechner,M.J. (2013) Mitochondria and FOXO3: breath or die. Frontiers in Physiology., 4:147. PubMed

Hagenbuchner,J., Kiechl-Kohlendorfer,U., Obexer,P. and Ausserlechner,M.J. (2013) A novel Mcl1 variant inhibits apoptosis via increased Bim sequestration. Oncotarget. ;4(8):1241-52. PubMed

Ausserlechner,M.J., Salvador,C., Deutschmann,A., Bodner,M., Viola,G., Bortolozzi,R., Basso,G., Hagenbuchner,J. and Obexer,P. (2013) Therapy-resistant acute lymphoblastic leukemia (ALL) cells inactivate FOXO3 to escape apoptosis induction by TRAIL and Noxa. Oncotarget, 4(7): 995- 1007. PubMed 

Hagenbuchner J, Kuznetsov AV, Obexer P, and Ausserlechner MJ (2013). BIRC5/Survivin enhances aerobic glycolysis and drug resistance by altered regulation of the mitochondrial fusion/fission machinery, Oncogene, 32(40):4748-57. PubMed

Geiger, K.*, Hagenbuchner, J.*, Rupp, M., Fiegl, H., Sergi, C., Meister, B., Kiechl-Kohlendorfer, U., Müller, T., Michael J. Ausserlechner, M.J. , Obexer, P. (2012). FOXO3/FKHRL1 is activated by 5-Aza-2-deoxycytidine (5-azadC) and induces silenced Caspase-8 in neuroblastoma. Molecular Biology of the Cell, 23(11): 2226-34. PubMed

Hagenbuchner, J., Kuznetsov, A. V., Hermann, M., Hausott, B., Obexer, P., Ausserlechner, M. J. (2012) FOXO3-induced reactive oxygen species are regulated by BCL2L11/Bim and SESN3. Journal of Cell Science. 125(PT5): 1191-203. PubMed 

Hagenbuchner, J., Ausserlechner, MJ., Porto, V., David, R., Meister, B., Bodner, M., Villunger, A., Geiger, K., Obexer, P. (2010) The Antiapoptotic Protein BCL2L1/BCL-XL is Neutralized by Proapoptotic PMAIP1/Noxa in Neuroblastoma Thereby Determining Bortezomib-Sensitivity Independent of Prosurvival MCL1 Expression. Journal of Biological Chemistry. 285(10):6904-12. PubMed

Berger, R., Fiegl, H., Goebel, G., Obexer, P., Ausserlechner, MJ., Doppler, W., Hauser-Kronberger, C., Reitsamer, R., Egle, D., Reimer, D., Müller-Holzner, E., Jones, A., Widschwendter, M. (2010) Toll-like Receptor-9 expression in breast and ovarian cancer is associated with poorly differentiated tumors. Cancer Science, 101(4):1059-66. PubMed 

Tominaga, K., Tominaga, E., Ausserlechner, MJ., Pereira-Smith, OM. (2010) The cell senescence inducing gene product MORF4 is regulated by degradation via the ubiquitin/proteasome pathway. Experimental Cell Research. 360(1): 92-102. PubMed

Obexer, P., Hagenbuchner, J., Rupp, M., Salvador, C., Holzner, M., Deutsch, M., Porto, V., Kofler, R., Unterkircher, T., Ausserlechner, MJ. (2009) p16^INK4Asensitizes human leukemia cells to FAS- and glucocorticoid-induced apoptosis via induction of BBC3/Puma and repression of MCL1 and BCL2. Journal of Biological Chemistry. 284(45): 30933-40. PubMed

Obexer, P., Hagenbuchner, J., Unterkircher, T., Sachsenmaier, N., Seifarth, C., Böck, G., Porto, V., Geiger,  K., Ausserlechner, MJ. (2009) Repression of BIRC5/Survivin by FOXO3/FKHRL1 sensitizes human neuroblastoma cells to DNA-damage-induced apoptosis.  Molecular Biology of the Cell,20(7), 2041-48. PubMed

Prelog M, Schwarzenbrunner N, Sailer-Höck M, Kern H, Klein-Franke A, Ausserlechner MJ, Koppelstaetter C, Brunner A, Duftner C, Dejaco C, Strasak AM, Müller T, Zimmerhackl LB, Brunner J. (2008) Premature aging of the immune system in children with juvenile idiopathic arthritis. Arthritis and Rheumatism, 58(7):2153-62. PubMed

Spoden GA, Mazurek S, Morandell D, Bacher N, Ausserlechner MJ, Jansen-Dürr P, Eigenbrodt E, Zwerschke W. (2008) Isotype-specific inhibitors of the glycolytic key regulator pyruvate kinase subtype M2 moderately decelerate tumor cell proliferation., International Journal of  Cancer. 123(2):312-21. PubMed

Obexer, P., Geiger, K., Ambros, P., Meister, B., Ausserlechner, M.J. (2007) FKHRL1-mediated expression of Noxa and Bim induces apoptosis via the mitochondria in neuroblastoma cells. Cell Death and Differentiation, 14(3), 534-547. PubMed

Ausserlechner, M.J., Obexer, P., Geiger, K., Deutschmann, A., Kofler, R. (2006) A retroviral expression system based on tetracycline-regulated tricistronic transactivator/repressor vectors for functional analyses of anti-proliferative and toxic genes  Molecular Cancer Therapeutics, 5(8), 1927-34. PubMed 

Agu, C.A., Klein, R., Schwab, S., Konig-Schwab, M., Kodajova, P., Ausserlechner, M. J., Binishofer, B., Blasi, U., Salmons, B., Günzburg, W. H., Hohenadl, C. (2006): The cytotoxic activity of the bacteriophage lambda-holin protein reduces tumour growth rates in mammary cancer cell xenograft models. Journal of Gene Medicine. 8(2), 229-241. PubMed

Bacher, N., Tiefenthaler, M., Sturm, S., Stuppner, H., Ausserlechner, M. J., Kofler, R., Konwalinka, G. (2006): Oxindole alkaloids from Uncaria tomentosa induce apoptosis in proliferating, G0/G1-arrested and bcl-2 expressing acute lymphoblastic leukaemia cells. British Journal of Haematatology. 132(5), 615-622. PubMed

Prelog, M., Bergmann, C., Ausserlechner, M.J., Fischer, H., Margreiter, R., Gassner, I., Brunner, A., Jungraithmayr, T.C., Zerres, K., Sergi, E.C. Zimmerhackl, L.B. (2006) Successful transplantation in a child with rapid progression of autosomal recessive polycystic kidney disease associated with a novel mutation. Pediatric  Transplantation. 10:362-366. PubMed

Ausserlechner, M. J., Obexer, P., Geley, S., Kofler, R. (2005): G1-arrest by p16^INK4A Uncouples Growth from Cell Cycle Progression in Leukemic Cells with Deregulated Cyclin E and c-Myc. Leukemia, 19(6), 1051-1057. PubMed

Ausserlechner, M. J., Obexer, P., Böck, G., Geley, S., and Kofler, R. (2004): Cyclin D3 and c-Myc Control Glucocorticoid-induced Cell Cycle Arrest but not Apoptosis in Lymphoblastic Leukemia Cells. Cell Death and Differentiation, 11(2), 165-174. PubMed

Riml, S., Schmidt, S., Ausserlechner, M.J., Geley, S., Kofler, R. (2004): Glucocorticoid receptor heterozygosity combined with lack of receptor auto-induction causes glucocorticoid resistance in Jurkat acute lymphoblastic leukemia cells. Cell Death and Differentiation, 11(S1), 65-72. PubMed

Villunger, A., Michalak, E., Coultas, L., Müllauer, F., Böck, G., Ausserlechner, M.J., Adams, J.M., Strasser, A. (2003): BH3-only Proteins Puma/Bbc3 and Noxa Are Limiting for Cytotoxic Drug-Induced Apoptosis. Science, 302, 1036-1038. PubMed

Renner, K., Ausserlechner, M.J., Kofler, R. (2003). A Conceptual View on Gluco­corticoid-Induced Apoptosis, Cell Cycle Arrest and Glucocorticoid Resistance in Lymphoblastic Leukemia. Current Molecular Medicine, 3, 707-717. PubMed

Kofler, R., Schmidt, S., Kofler, A., Ausserlechner, M.J., (2003): Resistance to Glucocorticoid-induced Apoptosis in Lymphoblastic Leukemia.  Journal of Endocrinology, 178, 19-27. PubMed

Larcher, C., Bernhard, D., Schaad, E., Adler, B., Ausserlechner, M.J., Mitterer, M., Huemer, H.P. (2003): Functional Analysis of the Mutated Epstein-Barr Virus LMP1 Oncoprotein (LMP-69del) from a Case of Persistent Polyclonal B-cell Lymphocytosis. Haematologica, 88(12), 1324-1335. PubMed

Ausserlechner, M. J., Obexer, P., Wiegers, G. J., Hartmann, B. L., Geley, S., and Kofler, R. (2001): The Cell Cycle Inhibitor p16/Ink4a Sensitizes Lymphoblastic Leukemia Cells to Apoptosis by Physiologic Glucocorticoid Levels. Journal of Biological Chemistry. 276, 10984-10989. PubMed

Ruefli, A. A., Ausserlechner, M. J., Bernhard, D., Sutton, V. R., Tainton, K., Kofler, R., Smyth, M. J., Johnstone, R. W. (2001): The Histone Deacetylase Inhibitor and Chemotherapeutic Agent Suberoylanilide Hydroxamic Acid (SAHA) Induces a Cell-death Pathway Characterized by Cleavage of Bid and Production of Reactive Oxygen Species. PNAS, 18, 10833-10838. PubMed

Tonko, M., Ausserlechner, M. J., Bernhard, D., Helmberg, A., and Kofler, R. (2001): Gene Expression Profiling of Proliferating Versus G1/G0 Arrested Human Leukemia Cells Suggests a Mechanism For Glucocorticoid-induced Apoptosis. The FASEB Journal, 15, 693-699. PubMed 

Bernhard, D., Tinhofer, I, Tonko, M., Hübl, H, Ausserlechner, M. J., Greil, R, Kofler, R., and Csordas, A.(2000): Resveratrol Causes Arrest in the S-phase prior to Fas-independent Apoptosis in CEM-C7H2 Acute Leukemia Cells. Cell Death and Differentiation, 7, 834-842. PubMed

Bernhard, D., Ausserlechner, M. J., Tonko, M., Loffler, M., Hartmann, B. L., and Kofler, R. (1999): Apoptosis Induced by the Histone Deacetylase Inhibitor Butyrate in Human Leukemic Lymphoblasts. The FASEB Journal, 13, 1991-2001. PubMed

Löffler, M., Ausserlechner, M. J., Tonko, M., Hartmann, B. L., Bernhard, D., Geley, S., and Kofler, R. (1999): C-Myc Does Not Prevent Glucocorticoid-induced Apoptosis of Human Leukemic Lymphoblasts. Oncogene, 18, 4626-4631. PubMed

Ausserlechner, M. J., Sgonc, R., and Wick, G. (1998): Chemiluminescence-based RNase Protection Assays for Simultaneous Quantification of Procollagen mRNAs Containing AU Rich Regions. Biotechniques 24, 366-370. PubMed

Ausserlechner, M. J., Sgonc, R., Dietrich, H., and Wick, G. (1997): Altered Procollagen mRNA Expression during the Progression of Avian Scleroderma. Molecular Medicine 3, 654-662. PubMed

Geley, S., Hartmann, B. L., Hattmannstorfer, R., Löffler, M., Ausserlechner, M. J., Bernhard, D., Sgonc, R., Strasser-Wozak, E. M. C., Ebner, M., Auer, B., and Kofler, R. (1997): p53-induced Apoptosis in the Human T-ALL Cell Line CCRF-CEM. Oncogene 15, 2429-2437. PubMed

Book Chapters

Ausserlechner, MJ, Hagenbuchner, J, Fuchs, S, Geiger, K, and Obexer, P (2011). FOXO transcription factors as potential therapeutic targets in neuroblastoma, pp. 325-348 In H. Shimada [ed.], Neuroblastoma - Present and Future. InTech, Rijeka, Croatia. Link

Obexer, P, Hagenbuchner, J, Holzner, M, and Ausserlechner, MJ (2011). p16INK4A - connecting cell cycle control to cell death regulation in human leukemia, pp. 115-130 In O. Babusikova, S. Dovat, and K. S. Payne [eds.], T-cell Leukemia. InTech, Rijeka, Croatia. Link

Kuznetsov AV, Javadov S, Ausserlechner MJ, Hagenbuchner J (2021). The Role of Cytoskeletal Proteins in the Regulation of Mitochondrial Function, pp 39-63 “Recent Research Advances in Biology” Vol. 8 https://doi.org/10.9734/bpi/rrab/v8/7822D

Kuznetsov, AV, Javadov, S, Hagenbuchner, J, Ausserlechner, MJ (2021). Mitochondrial Involvement in the Molecular Mechanisms of Ischemia-Reperfusion Injury in the Heart, pp 64-87, in “Recent Research Advances in Biology” Vol. 8,  https://doi.org/10.9734/bpi/rrab/v8/7823D

Wilfingseder D and Ausserlechner MJ. (2021) Dreidimensionale (3D-)Kulturen, Organoide und 3D-Biodruck, pp311-323, in „Zell und Gewebekultur“ Gstraunthaler G and Lindl T, Springer Spektrum https://doi.org/10.1007/978-3-662-62606-1

Kuznetsov, AV*, Hagenbuchner, J, Ausserlechner, MJ* (2021). ROS flashes in mitochondria occur concomitantly with inner mitochondrial membrane depolarization and mitochondrial calcium sparks, in “Recent Research Advances in Biology” https://doi.org/10.9734/bpi/nfmmr/v16/1816C

Hagenbuchner, J, Obsilova, V, Obexer, P, Obsil, T*, Ausserlechner, MJ* (2021). Discovery of Small Compounds that Target FOXO Transcription Factors and Modulate their Transcriptional Activity and Physiological Function, pp 41-54, in “New Innovations in Chemistry and Biochemistry” Vol. 4, https://doi.org/10.9734/bpi/nicb/v4/14349D